(4S,4'S)-4,4'-Diisopropyl-1,1'-diphenyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

Ethyl 2-amino-2-cyclohexylacetate, 98%, 250mg

ETHYL 2-((TETRAHYDRO-2H-PYRAN-2-YL)OXY)CYCLOPROPANE-1-CARBOXYLATE, 95.0%, 50mg

Infinity corrected plan semi apochromatic PL-M 100x/0.80 IOS objective. Working distance 2.1 mm

3,5-DIMETHYL-1-(TETRAHYDRO-2H-PYRAN-4-YL)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-1H-PYRAZOLE, 95.0%, 1g

N,N'-bis(2-phenylethyl)urea, 100mg

1-(Bromomethyl)-3,5-dichlorobenzene, 95.0%, 1g

6-(1H-imidazol-1-yl)-1,3-benzothiazol-2-amine, 95.0%, 250mg

1-tert-Butoxycarbonyl-1H-indole-3-acetamide, 98%, 250mg

tert-Butyl 2-oxo-4-oxa-1,9-diazaspiro[5.5]undecane-9-carboxylate, 95%, 500mg

3-Methyl-1H-indazol-5-yl-5-boronic acid, 95.0%, 10g

2-Methyl-1-(3-sulphonatopropyl)quinolinium, 95.0%, 100g

3-(3-hydroxyquinoxalin-2-yl)propanoic acid, 95.0%, 25g